Cargando…

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

Sample size derivation is a crucial element of planning any confirmatory trial. The required sample size is typically derived based on constraints on the maximal acceptable Type I error rate and minimal desired power. Power depends on the unknown true effect and tends to be calculated either for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunzmann, Kevin, Grayling, Michael J., Lee, Kim May, Robertson, David S., Rufibach, Kaspar, Wason, James M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612172/ https://www.ncbi.nlm.nih.gov/pubmed/34992303 http://dx.doi.org/10.1080/00031305.2021.1901782

Ejemplares similares

Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials
por: Kunzmann, Kevin, et al.
Publicado: (2022)

Design of experiments for a confirmatory trial of precision medicine
por: Lee, Kim May, et al.
Publicado: (2019)

Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

Bayesian modelling strategies for borrowing of information in randomised basket trials
por: Ouma, Luke O., et al.
Publicado: (2022)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

A web application for the design of multi-arm clinical trials
por: Grayling, Michael J., et al.
Publicado: (2020)

Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges
por: Ursino, Moreno, et al.
Publicado: (2021)

Point estimation following a two-stage group sequential trial
por: Grayling, Michael J, et al.
Publicado: (2022)

Response adaptive intervention allocation in stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2022)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study
por: Wych, Julie, et al.
Publicado: (2019)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Group sequential crossover trial designs with strong control of the familywise error rate
por: Grayling, Michael J., et al.
Publicado: (2018)

Developing a composite outcome measure for frailty prevention trials – rationale, derivation and sample size comparison with other candidate measures
por: Witham, Miles D., et al.
Publicado: (2020)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
por: Grayling, Michael J., et al.
Publicado: (2017)

Evaluating Model Fit in Bayesian Confirmatory Factor Analysis With Large Samples: Simulation Study Introducing the BRMSEA
por: Hoofs, Huub, et al.
Publicado: (2017)

Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods
por: Ouma, Luke Ondijo, et al.
Publicado: (2021)

Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing
por: Best, Nicky, et al.
Publicado: (2021)

A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation
por: Sarkodie, Samuel K, et al.
Publicado: (2022)

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)

Design and analysis of umbrella trials: Where do we stand?
por: Ouma, Luke O., et al.
Publicado: (2022)

Bayesian sample size determination for diagnostic accuracy studies
por: Wilson, Kevin J., et al.
Publicado: (2022)

Bayesian Update with Importance Sampling: Required Sample Size
por: Sanz-Alonso, Daniel, et al.
Publicado: (2020)

Genomic Bayesian Confirmatory Factor Analysis and Bayesian Network To Characterize a Wide Spectrum of Rice Phenotypes
por: Yu, Haipeng, et al.
Publicado: (2019)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
por: Grayling, Michael J., et al.
Publicado: (2022)

Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential
por: Grayling, Michael J., et al.
Publicado: (2021)

Including non-concurrent control patients in the analysis of platform trials: is it worth it?
por: Lee, Kim May, et al.
Publicado: (2020)

Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021)

Confirmatory Tissue Sampling in Clinical Stage I Sarcoidosis
por: Reich, Jerome M.
Publicado: (2020)

Sample size determination for Bayesian ANOVAs with informative hypotheses
por: Fu, Qianrao, et al.
Publicado: (2022)

Bayesian sample size determination for cost-effectiveness studies with censored data
por: Beavers, Daniel P., et al.
Publicado: (2018)

Bayesian design and analysis of external pilot trials for complex interventions
por: Wilson, Duncan T., et al.
Publicado: (2021)

Exploratory and Confirmatory Bayesian Networks Identify the Central Role of Non-judging in Symptoms of Depression
por: Rubin, Mikael, et al.
Publicado: (2021)

Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial
por: McMenamin, Martina, et al.
Publicado: (2021)

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
por: Mossop, Helen, et al.
Publicado: (2021)

Turning the hands of time again: a purely confirmatory replication study and a Bayesian analysis
por: Wagenmakers, Eric-Jan, et al.
Publicado: (2015)

Bayesian Estimation of Population Size Changes by Sampling Tajima’s Trees
por: Palacios, Julia A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gs3bkbqjkhh44fsm17rogeq6ck